188 related articles for article (PubMed ID: 20003141)
1. Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.
Celebi S; Hacimustafaoglu M; Koksal N; Ozkan H; Cetinkaya M
Pediatr Int; 2010 Jun; 52(3):410-4. PubMed ID: 20003141
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
3. Old agent, new experience: colistin use in the paediatric Intensive Care Unit--a multicentre study.
Paksu MS; Paksu S; Karadag A; Sensoy G; Asilioglu N; Yildizdas D; Akyildiz BN; Kendirli T; Demirkol D; Akgun M; Alp E; Ciftci E; Guney AK; Murat N
Int J Antimicrob Agents; 2012 Aug; 40(2):140-4. PubMed ID: 22727770
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
6. Intravenous colistin administration in neonates.
Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
[TBL] [Abstract][Full Text] [Related]
7. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
[TBL] [Abstract][Full Text] [Related]
8. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
Mekonnen H; Seid A; Molla Fenta G; Gebrecherkos T
PLoS One; 2021; 16(11):e0257272. PubMed ID: 34780494
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.
İşgüder R; Ağın H; Ceylan G; Bayram N; Devrim İ
Am J Infect Control; 2016 Jun; 44(6):734-5. PubMed ID: 26921012
[No Abstract] [Full Text] [Related]
11. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study.
Motbainor H; Bereded F; Mulu W
BMC Infect Dis; 2020 Jan; 20(1):92. PubMed ID: 32000693
[TBL] [Abstract][Full Text] [Related]
13. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
[TBL] [Abstract][Full Text] [Related]
14. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Celik IH; Oguz SS; Demirel G; Erdeve O; Dilmen U
Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011
[TBL] [Abstract][Full Text] [Related]
15. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
16. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
17. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
18. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Levin AS; Barone AA; Penço J; Santos MV; Marinho IS; Arruda EA; Manrique EI; Costa SF
Clin Infect Dis; 1999 May; 28(5):1008-11. PubMed ID: 10452626
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
[TBL] [Abstract][Full Text] [Related]
20. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
